Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -254.74 | -32.81 |
PEG Ratio (TTM) | 1.29 | -2.60 |
P/S Ratio (TTM) | N/A | 34.48 |
P/B Ratio (TTM) | 10.88 | 6.92 |
P/FCF Ratio (TTM) | -28.14 | -186.97 |
Price to 5YR AVG Earnings Ratio | N/A | -29.47 |
Price to 5YR AVG FCF Ratio | N/A | -26.96 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -1.53% | 47.18% |
ROE (TTM) | -0.55% | -531.00% |
Net Profit Margin (TTM) | N/A | -258.93% |
ROIC 5YR AVG | N/A | 831.88% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -197.99% | 4,866.43% | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -200.96% | 3,490.36% | N/A |
Cash Flow | 4.99% | 574,844.25% | N/A |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.24 | 4.81 |
Quick Ratio (TTM) | 0.24 | 24.13 |
D/E Ratio (TTM) | 0.46 | 0.23 |
Interest Coverage (TTM) | N/A | 2.72 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | N/A | 21.17 |
LTL to 5YR AVG FCF | N/A | -1.27 |
Shares Outstanding Growth 5YR AVG | N/A | 515.68% |